NCT05714553 2025-07-18NUC-3373 in Combination With Other Agents in Patients With Advanced Solid TumoursNuCana plcPhase 1/2 Terminated19 enrolled
NCT03387085 2024-08-09QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.ImmunityBio, Inc.Phase 1/2 Terminated9 enrolled 18 charts
NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT00005608 2012-06-06Fluorouracil-Uracil and Leucovorin in Treating Women With Metastatic Breast CancerNorthwestern UniversityPhase 2 Terminated
NCT00044785 2005-06-24Phase I Study of PN401, Fluorouracil, Leucovorin and CPT-11 in Patients With Solid TumorsWellstat TherapeuticsPhase 1 Terminated24 enrolled